Intage Holdings Inc. TSE:4326
INTAGE : Supplementary Materials for Consolidated Financial Results for the Three Months Ended September 30, 20241277KB
Source: MarketScreener
Supplementary Materials for
Consolidated Financial Results for the Three Months Ended September 30, 2024
INTAGE HOLDINGS Inc.
Security code: 4326
November 6, 2024
Summary of Consolidated Statements of Income | 2 |
Net sales increased primarily due to sales growth at INTAGE Research, Inc., Buildsystem Co., Ltd., and Research and Innovation Co., Ltd., as well as the consolidation of DOCOMO InsightMarketing, INC. However, profit decreased chiefly due to higher personnel and other expenses associated with the inclusion of the new consolidated subsidiary and an increase in projects. Additionally, there were greater investments aimed at expanding the business domains. Profit attributable to owners of parent rose compared to the year-ago period due to a gain on sale of businesses related to the transfer of the CRO (contract research organization) business, which was recorded as extraordinary income.
Consolidated Statements of Income | (Millions of yen) | |||||||
3 months ended | 3 months ended | 3 months ending | Progress vs | |||||
Y/Y (%) | full-year plan | Full-year plan | 2Q Plan | |||||
Sep. 30, 2023 | Sep. 30, 2024 | Sep. 30, 2025 | ||||||
(%) | ||||||||
Net sales | 14,119 | 14,306 | 15,057 | +5.2% | 22.1% | 68,000 | 32,500 | |
Operating | 13,545 | 14,108 | 14,870 | +5.4% | ー | ー | ー | |
expenses | ||||||||
Operating profit | 573 | 198 | 187 | △5.7% | 4.9% | 3,800 | 1,100 | |
Ordinary profit | 907 | 314 | 106 | △66.1% | 2.8% | 3,800 | 1,100 | |
Profit attributable | 691 | 150 | 1,132 | +653.8% | 30.6% | 3,700 | 2,000 | |
parent | ||||||||
to owners of | ||||||||
EPS (yen) | 17.66 | 3.95 | 29.70 | ー | ー | 97.04 | 52.48 | |
©INTAGE GROUP
Executing Actions in Accordance with the Basic Policies of the Medium- | 3 |
Term Management Plan and Business Plan |
Basic policy of the 14th Medium-Term
Management Plan
Towards New Portfolio as a Data + Technology Company - Creation of new value -
Basic policy of the FY2024 business plan
ーSynergy ＆ Optimizationー Promoting Group synergies and optimizing core businesses
Expanding business | Optimizing Group |
domains | management resources |
DOCOMO InsightMarketing, INC. has become a wholly owned subsidiary.
When the Company became a subsidiary of NTT DOCOMO, INC. in October 2023, it began considering making DOCOMO InsightMarketing, INC. (DIM) , which was a joint venture with NTT DOCOMO, a wholly owned subsidiary. On July 1, 2024, DIM became a wholly owned subsidiary. The Company believes that as a wholly owned subsidiary, DIM can make agile management decisions and integrate service production and sales, which will enhance business efficiency. This allows DIM to respond more quickly to customer needs and deliver services that meet customer expectations. Consequently, DIM is expected to contribute more significantly to the Companyʼs business results.
The CRO business of INTAGE Healthcare Inc. has been transferred to Alfresa Holdings Corporation.
The Company transferred the CRO business to Alfresa Holdings Corporation on September 2, 2024. The Company faces diverse challenges in the healthcare field. In this environment, the Company decided to focus on enhancing the value of data, where it excels, and to concentrate its management resources on the marketing research business and data science businesses. Alfresa Holdings is developing a comprehensive supply chain that encompasses drug development, manufacturing, sales, distribution, and PMS*. Alfresa decided that acquiring the CRO business would provide the resources, expertise, and trusting relationships with customers that would contribute to enhancing the functions of the supply chain that it is developing.
GROUP
- PMS : Post Marketing Surveillance
Factors Contributing to Changes in Operating Profit | 4 |
Sales increased by 751 million yen but fell short of the forecast. The increase in sales was more than offset by an increase in expenses, including 313 million yen in personnel expenses, 223 million yen in costs, and 144 million yen in investments, leading to a decrease in operating profit.
198
Higher sales | OP for three months | ||||||||||||
(Millions of yen) | OP for three months | Variable costs | Personnel expenses | Costs | Investment | ||||||||
ended September | ended September | ||||||||||||
30, 2023 | 30, 2024 | ||||||||||||
Net sales
Costs and personnel
expenses
Investment
- Higher sales at INTAGE Research, Inc. and Research and Innovation Co., Ltd.
- Sales at DOCOMO InsightMarketing, INC., which has become a consolidated subsidiary in the current fiscal year, were recorded.
- Personnel expenses increased, reflecting an increase in personnel at INTAGE, Inc. and the consolidation of DOCOMO InsightMarketing, INC. Outsourcing costs and expenses related to product procurement and data purchase rose due to increased projects and the consolidation of DOCOMO InsightMarketing.
- Investments in the revamp of SCI and the CX Marketing Platform increased.
©INTAGE GROUP
Trend in quarterly results | 5 | |
(Millions of yen) | Trend in net sales | (Millions of yen) Trend in operating profit |
20,000 | 3,000 | |||
18,000 | 17,929 17,609 | 2,500 | ||
16,432 | ||||
16,000 | 15,057 | 15,841 | 14,931 | 2,000 |
14,306 | ||||
14,000 | 14,119 | 1,500 | ||
13,498 | ||||
12,000 | 1,000 | |||
10,000 | 500 | |||
0 | ||||
8,000 | ||||
１Q（7～9） ２Q（10～12） ３Q（1～3） | ４Q（4～6） | -500 | ||
2,070 | |
1,778 | |
1,403 1,332 | |
573 | |
198 | 187 |
-19 | |
-261 | |
１Q（7～9） ２Q（10～12） ３Q（1～3） ４Q（4～6） |
Year ended | Year ended | Year ending | ||
June 30, 2023 | June 30, 2024 | June 30, 2025 | ||
©INTAGE GROUP
Performance by Segment: Marketing Support (Consumer Goods & Services) | 6 |
Net sales breakdown by product
(Millions of yen) |
Operating |
Other | 825 |
Overseas | 1,293 |
Co | 578 |
CR other than Web | 767 |
CR-Ｗeb | 1,821 |
Panel surveys | 3,728 |
(Millions of yen)
3 months ended
Sep. 30, 2023
+43%
+14%
+39%
+18%
+7%
+1%
1,179
1,470
803
905
1,954
3,752
3 months ended
Sep. 30, 2024
23/9 | 24/9 | Y/Y | profit margin |
Net sales | 9.015 | 10,066 | +11.7% | |
Operating | -295 | -290 | - | - |
profit | ||||
• | The results of the mainstay panel surveys and customer research were |
mostly unchanged year on year. | |
• INTAGE Research, Inc. and Research and Innovation Co., Ltd. posted | |
healthy sales. | |
• | DOCOMO InsightMarketing, INC., which was consolidated in the current |
fiscal year, made a significant contribution to the increase in net sales. | |
• In overseas business, sales increased year on year. |
Other: Public-sector projects, RnI’s CODE, etc.
Overseas: Sales from overseas subsidiaries (excluding healthcare)
Co: Communications area (i-SSP, Media Gauge, di-PiNK, etc.)
CR (Other than Web): Custom research through methods other than Internet surveys (such as qualitative research, offline survey, and outbound) CR-Web:Internet surveys of custom research areas
Panel surveys: SRI+, SCI, etc.
• Despite the increase in sales, the Company recorded an operating loss that |
was roughly equal to the year-ago level. This loss was primarily due to |
investment expenses, personnel expenses, and upfront expenses related to |
launching a new business anticipated to create synergies with NTT |
DOCOMO, INC. |
*Sales of DOCOMO InsightMarketing, INC are recorded in CR, Co and Other in the left graph.
©INTAGE GROUP
Performance by Segment: Marketing Support (Healthcare) | 7 |
Net sales breakdown by product | (Millions of yen) | |||||||
Other | 121 | 121 | 23/9 | 24/9 | Y/Y | Operating | ||
profit margin | ||||||||
Promotion | 743 | -8% | ||||||
683 | Net sales | 3,353 | 3,184 | -5.0% | ||||
CRO | 664 | -51% | 324 | Operating | 255 | 279 | +9.8% | 8.8% |
profit | ||||||||
CR 967 +21% 1,167
Panel surveys | 856 | +4% | 887 |
(Millions of yen) | 3 months ended | 3 months ended | |
Sep. 30, 2023 | Sep. 30, 2024 |
Other: Healthcare sales of overseas subsidiaries, etc.
Promotion: Sales from promotion-related business conducted by KYOWA KIKAKU Ltd.
CRO (Contract Research Organization): Post-marketing surveillance, etc.
CR: Custom research mainly for pharmaceutical companies and medical device manufacturers
Panel surveys: SRI+, Impact Track, prescription DB, etc.
- Despite a decline in sales from selling the CRO business, segment profitability improved significantly.
- Both net sales and operating profit from custom research in the medical field of the mainstay research business of INTAGE Healthcare Inc. exceeded the levels of the year-ago period.
- Custom research contributed to increase of the Segment’s operating profit.
As described in the Notice of Company Split (Incorporation-Type Company Split) and Transferring Shares of a Newly- Incorporated Company by a Consolidated Subsidiary Company, and Recording of Extraordinary Profit dated June 17, 2024, our consolidated subsidiary, INTAGE Healthcare Inc. transferred its CRO business to Alfresa Holdings Corporation on September 2, 2024.
20240709101853294s.pdf
©INTAGE GROUP
Performance by Segment: Business Intelligence | 8 |
Net sales breakdown by area
DX | 531 | +28% | |
678 | |||
BPO | 512 | -5% | |
488 | |||
SI | 895 | -28% | 642 |
(Millions of yen) | |||
3 months ended | 3 months ended | ||
Sep. 30, 2023 | Sep. 30, 2024 |
DX: Support for promotion of DX-related areas in companies
BPO and maintenance operations: BPO services such as business process efficiency improvement, system maintenance and management, etc.
SI: System development, etc.
(Millions of yen) | ||||
23/9 | 24/9 | Y/Y | Operating | |
profit margin | ||||
Net sales | 1,938 | 1,807 | -6.8% | |
Operating | 239 | 197 | -17.6% | 10.9% |
profit | ||||
- Both sales and profit were in line with the plan.
- The data integration platform business, a new priority investment field, performed well. However, net sales were below the year-ago level due to the lack of large-scale projects in the travel area in the previous fiscal year.
- The results of Buildsystem Co., Ltd. surpassed the year-ago level due to the strong performance of low-code development projects.
- Profit also declined due to the lack of large-scale projects in the year-ago
period.
INTAGE TECHNOSPHERE Inc. business lineup
INTAGE TECHNOSPHERE aims to provide IT solutions to INTAGE Group clients. The company's business includes building and operating systems, and managing data centers.
Examples of solutions: Payment systems for travel agencies, health management support services, pharmaceutical companies’ sales information systems, publishing POS systems, trade area analyses, AI solutions.
©INTAGE GROUP
d Mileage Launched (jointly by three companies on September 17, 2024) | 9 |
On Tuesday,September 17, 2024, d Mileage point rewards were launched. The new program allows customers to earn d POINTs by purchasing eligible products and registering the receipts and product barcodes. The program offers comprehensive support to manufacturers and other businesses that do not have a customer database. It helps them attain new customers, foster repeat purchases, build brand loyalty, and evaluate effectiveness using accumulated purchase data.
Overview of the
program
Customers can earn stamps by purchasing eligible products and registering the receipts and product barcodes on the d POINT CLUB app, d Payment® app, or d POINT CLUB website. No specific stores or payment methods are designated, and customers can earn valuable d POINTs simply by purchasing eligible products at their usual stores with their preferred payment methods.
* d Payment is a registered trademark of NTT DOCOMO, INC.
Role of each company
NTT DOCOMO, INC.
Making the program available to d POINT CLUB members and manufacturers
INTAGE, Inc.
Providing manufacturers with integrated, data-driven marketing planning, from action plans based on consumer understanding to proposals for subsequent actions following initial implementation and effectiveness verification
Research and Innovation Co., Ltd.
Providing patents and expertise in product identification using receipts and barcodes
＊* For more information, please refer to the press release dated September 17, 2024 (Japanese only).
https://www.intage.co.jp/news/2736/
©INTAGE GROUP